World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
16753
World Ranking
2749
National Ranking
1310

Carol Clayberger publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carol Clayberger sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 183 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carol Clayberger D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carol Clayberger sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Carol Clayberger is affiliated with Northwestern University in the United States. Their research primarily focuses on the fields of biochemistry, genetics, molecular biology, and medicine, with particular attention to genetics and molecular biology as subfields of study.

The main topics that define Clayberger's research work include:

  • Kruppel-like factors research
  • Genetic Syndromes and Imprinting
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Their recent scholarly contributions include the publication titled KLF13 promotes SLE pathogenesis by modifying chromatin accessibility of key proinflammatory cytokine genes, published in 2024 in the journal Communications Biology.

Clayberger frequently collaborates with several coauthors, including:

  • Andrew Wang
  • Anna-Marie Fairhurst
  • Kui Liu
  • Benjamin Wakeland
  • Spencer Barnes

Communications Biology is the main publication venue for their recent work.

Best Publications

  • CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

    Weihong Liu;Amy L Putnam;Zhou Xu-yu;Gregory L. Szot

  • Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

    Padmini Salgame;John S. Abrams;Carol Clayberger;Harris Goldstein

  • A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.

    Russell D. Salter;Richard J. Benjamin;Pamela K. Wesley;Sarah E. Buxton

  • A human T cell-specific molecule is a member of a new gene family.

    Thomas J. Schall;Jan Jongstra;Bradley J. Dyer;Jeffrey L Jorgensen

  • Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon.

    Jordan S. Pober;Tucker Collins;Michael A. Gimbrone;Ramzi S. Cotran

  • Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8.

    Russell D. Salter;Anne M. Norment;Benjamin P. Chen;Carol Clayberger

  • Granulysin, a T Cell Product, Kills Bacteria by Altering Membrane Permeability

    William A. Ernst;Sybille Thoma-Uszynski;Rachel Teitelbaum;Christine Ko

  • Biology and clinical relevance of granulysin

    A. M. Krensky;C. Clayberger

  • Cytotoxic Cells Kill Intracellular Bacteria through Granulysin-Mediated Delivery of Granzymes

    Michael Walch;Farokh Dotiwala;Sachin Mulik;Jerome Thiery

  • A Distinct Pathway of Cell-Mediated Apoptosis Initiated by Granulysin

    Allan A. Kaspar;Satoshi Okada;Jayant Kumar;Francis R. Poulain

  • Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the α2 domain of HLA-A2

    Peter Parham;Carol Clayberger;Sherri L. Zorn;David S. Ludwig

  • Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily.

    Peter L. Wang;Susan O'Farrell;Carol Clayberger;Alan M. Krensky

  • Specificity of OKT4+ cytotoxic T lymphocyte clones.

    A M Krensky;C Clayberger;C S Reiss;J L Strominger

  • The isolation and sequence of a novel gene from a human functional T cell line.

    Jan Jongstra;Thomas J. Schall;Bradley J. Dyer;Carol Clayberger

  • Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma

    Edward L. Nelson;Xioabin Li;Frank J. Hsu;Larry W. Kwak

  • ABSENCE OF CELL SURFACE LFA-1 AS A MECHANISM OF ESCAPE FROM IMMUNOSURVEILLANCE

    Carol Clayberger;L. Jeffrey Medeiros;Michael P. Link;Roger A. Warnke

  • Intracellular mediators of granulysin-induced cell death.

    Satoshi Okada;Qing Li;John C. Whitin;Carol Clayberger

  • Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin

    Zhuo Wang;Edward Choice;Allan Kaspar;Dennis Hanson

  • HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes.

    Carol Clayberger;Peter Parham;Jonathan Rothbard;David S. Ludwig

  • A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection.

    Richard Horuk;Carol Clayberger;Alan M. Krensky;Zhaohui Wang

Frequent Co-Authors

Alan M. Krensky
Alan M. Krensky Northwestern University
Peter Parham
Peter Parham Stanford University
Rosemarie H. DeKruyff
Rosemarie H. DeKruyff Stanford University
Harvey Cantor
Harvey Cantor Harvard University
Steven J. Burakoff
Steven J. Burakoff Icahn School of Medicine at Mount Sinai
Margaret E. Billingham
Margaret E. Billingham Stanford University
Victor H. Engelhard
Victor H. Engelhard University of Virginia
Mark M. Davis
Mark M. Davis Stanford University
Howard Rasmussen
Howard Rasmussen Augusta University
Gary K. Schoolnik
Gary K. Schoolnik Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, diversifying skills through related healthcare degrees can open numerous career opportunities. Nursing programs, in particular, provide an excellent pathway to roles that integrate patient care with immunological knowledge.

Many students consider enrolling in the easiest ABSN program to get into to quickly transition into nursing. These accelerated programs are designed for non-nurses seeking efficient entry into the profession without sacrificing quality.

For those without a nursing background, the best online BSN programs for non nurses offer flexible learning options. These programs help build foundational knowledge necessary for advanced practice and research roles.

Advancing further, graduates often pursue the accelerated FNP program to become Family Nurse Practitioners, expanding their clinical expertise.

Additionally, specialized credentials like the acute care NP certification can further enhance career prospects by focusing on critical care, which is closely related to immunological disorders and treatment.

Best Scientists Citing Carol Clayberger

Trending Scientists

Recently Published Articles